Abstract:Abstract Objective The present study was aimed to determine the differentially expressed proteins (DEPs) between paired samples of cervical cancer (CC) and paracancerous tissue by quantitative proteomics and to examine the effects of DUSP7 expression on tumorigenesis and progression of CC. Materials and methods Proteomic profiles of three paired samples of CC and paracancerous tissue were quantitatively analyzed to identify the DEPs. The gene functions of the DEPs were presented based on bioinformatics analysis in combining with bibliographical information. The expression of the DEPs was validated by IHC examination in the CC tissue arrays. The relationship between the DEPs expression and patients’ clinicopathological characteristics and prognosis were evaluated using the Spearman rank correlation test and Kaplan-Meier survival analysis respectively. The effects of the selected DEPs on CC progression were examined in SIHA (human CC cell line) cells. Results According to the TMT (Tandem Mass Tags) ratios (≥ 1.5 or ≤ 0.5 ), a total of 129 proteins were found to be differentially expressed in all 3 pairs of samples with a p value < 0.05. To investigate gene functions of these DEPs in tumor growth and progresssion, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed. Three DEPs, HRAS, DUSP7, and PLD1, and P-ERK1/2, associated with RAS pathway, were selected for further investigation. Western Blot and IHC staining analyses confirmed the results from quantitative proteomic analysis showing that HRAS, P-ERK1/2, and PLD1 levels were increased whereas DUSP7 level was decreased in CC tissue compared with the paired normal paracancerous tissues. The IHC results from the CC TMA analysis showed that the decreased expression of DUSP7 (P = 0.045 and 0.044, respectively) and increased expression of PLD1 (P = 0.046 and 0.028, respectively) were significantly associated with a tumor size > 2 cm and parametrial infiltration. In addition, the decreased expression of DUSP7 and increased expression of PLD1 and p-ERK1/2 were adversely related to patients’ relapse (P = 0.003, 0.040, and 0.001, respectively) and survival (P = 0.034, 0.001, and 0.006, respectively). The expression of HRAS and p-ERK1/2 was decreased in DUSP7-SIHA cells compared to NC-SIHA cells (P = 0.0003 and 0.0026, respectively). Biological functions in vitro, including invasion, migration, and proliferation, and tumor formation in vivo were decreased in the DUSP7-SIHA cells (all P < 0.05), yet increased in the siDUSP7-SIHA cells (all P < 0.05). Conclusions DUSP7 is decreased in cervical cancer tissues compared to normal tissues. Increasing or decreasing DUSP7 expression was found to significantly reduce or enhance the anchorage-independent growth of SIHA cells, respectively. The biological function of DUSP7 is possibly achieved through dephosphorylation of the ERK1/2 and inactivation of the RAS pathway. Up-regulating the expression of DUSP7 may be potential useful for the prevention or treatment of CC.

Human Papillomavirus Type 16 Early Protein E7 Activates Autophagy Through Inhibition of Dual-Specificity Phosphatase 5

Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR

Effects of Human Papillomavirus Type 16 E7 Protein on the Growth of Cervical Carcinoma Cells and Immuno-Escape Through the TGF-β1 Signaling Pathway

Digital RNA Sequencing of Human Epidermal Keratinocytes Carrying Human Papillomavirus Type 16 E7

Influence of Human Papillomavirus E7 Oncoprotein on Maturation and Function of Plasmacytoid Dendritic Cells in Vitro

Human Papillomavirus 16E6/E7 Activates Autophagy Via Atg9B and LAMP1 in Cervical Cancer Cells

Autophagy is Induced in Human Keratinocytes During Human Papillomavirus 11 Pseudovirion Entry

Hpv E7 Inhibits Cell Pyroptosis By Promoting Trim21-Mediated Degradation And Ubiquitination Of The Ifi16 Inflammasome

Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424–5p/suppressor of zeste 12 pathway

Induction of Co-Inhibitory Molecule CTLA-4 by Human Papillomavirus E7 Protein Through Downregulation of Histone Methyltransferase JHDM1B Expression

DUSP7 inhibits cervical cancer progression by inactivating the RAS pathway

Reduced Expression of Autophagy Markers Correlates with High-Risk Human Papillomavirus Infection in Human Cervical Squamous Cell Carcinoma

E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the EGFR and c-MET Oncogenes by Destabilizing the Histone Demethylase KDM5C.

Human Papillomavirus-16 E6 Activates the Pentose Phosphate Pathway to Promote Cervical Cancer Cell Proliferation by Inhibiting G6PD Lactylation

HPV E6/E7: Insights into Their Regulatory Role and Mechanism in Signaling Pathways in HPV-associated Tumor

Data from E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the <i>EGFR</i> and <i>c-MET</i> Oncogenes by Destabilizing the Histone Demethylase KDM5C

Human Papilloma Virus and Autophagy

High-Risk Human Papillomavirus E7 Maintains Stemness Via APH1B in Cervical Cancer Stem-Cell Like Cells.

Human Papillomavirus 16 Oncoprotein Regulates the Translocation of Β‐catenin Via the Activation of Epidermal Growth Factor Receptor

E3 Ubiquitin Ligase E6ap-Mediated Tsc2 Turnover In The Presence And Absence Of Hpv16 E6

HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.